In the first week of the new year, the performance of the A-share market exceeded investors\’ expectations, but in the view of some professional investors, the moment may be the moment of “others fear my greed”.
According to the data, as of January 7, a total of 150 stocks were recommended by securities companies this week (January 3-7). In terms of industry, basic chemical industry, power equipment, medicine and biology are the most densely distributed.
150 stocks were recommended to buy
Since it hit a new high of 314.57 yuan / share in early July 2021, Bloomage Biotechnology Corporation Limited(688363) has started the continuous callback mode. As of the closing on January 7, 2022, the company’s share price closed at 138.80 yuan / share, half of the previous historical high price. However, in a research report recently released by Caixin securities, the company still maintained a “recommended” rating and said that it was optimistic about its long-term development.
Bloomage Biotechnology Corporation Limited(688363) recent share price
(July 5, 2021 to January 7, 2022)
Why are you so optimistic about this medical US stock? The research report believes that as a global leader in hyaluronic acid raw materials, Bloomage Biotechnology Corporation Limited(688363) has prominent cost advantages and occupies a high-quality track. The moat is deep, which deserves long-term attention. It is estimated that the net profit attributable to the parent company from 2021 to 2023 will be 831 million yuan, 1211 million yuan and 1.838 billion yuan respectively.
There is also Ping An Bank Co.Ltd(000001) whose share price has fallen sharply but still recommended by securities companies. As of the closing on January 7, 2022, Ping An Bank Co.Ltd(000001) shares closed at 17.20 yuan / share, more than 30% higher than the new high of 25.16 yuan / share on May 27, 2021. Recently Zheshang Securities Co.Ltd(601878) gave Ping An Bank Co.Ltd(000001) a “buy” rating in the released research report, believing that the stock price was adjusted to the value range, creating an excellent opportunity for investment in the new year.
Ping An Bank Co.Ltd(000001) recent share price
(May 27, 2021 to January 7, 2022)
Data show that this week, securities companies gave buy ratings to 150 stocks. In terms of the overall industry distribution, 150 stocks rated “buy” by securities companies cover 27 of the 31 shenwanyi industries, with the largest number of stocks subordinate to the basic chemical industry, totaling 18; Followed by power equipment and pharmaceutical biology, with 17 and 16 subordinate stocks respectively.
Recommended to buy stocks in the top ten industries with the most intensive distribution
optimistic about deterministic growth opportunities and valuation repair
From the recent trend of the industry sector, the data show that the basic chemical sector has been in a shock state after the high level fell since late January 2021. The power equipment industry has continued to adjust after reaching a new high in the index in late November 2021, and the pharmaceutical and biological sector has started to callback since late July 2021.
Will the above industry sectors regain their gains in the future?
As for the basic chemical sector, Zheshang Securities Co.Ltd(601878) pointed out in the industry strategy for 2022 that the prosperity of the chemical industry has declined, and it is suggested to look for deterministic growth opportunities in 2022. From the perspective of valuation, it is recommended to pay attention to the sub sectors with low value and high profit, including chemical fiber (viscose, spandex and vinylon), agrochemical (nitrogen fertilizer and phosphorus fertilizer), soda ash, chlor alkali and polyurethane; From the perspective of commodity prices, it is suggested to screen from the perspective of commodity boom sustainability and bottom reversal, and pay attention to petrochemical industry chain, coal chemical industry, soda ash, fluorine chemical industry and vitamins.
For the power equipment industry, Citic Securities Company Limited(600030) believes that the demand of the photovoltaic industry is expected to accelerate in 2022, and focuses on high-quality companies in photovoltaic silicon materials, adhesive films, modules, inverters and equipment; In terms of wind power, the supply chain management and control ability of leading manufacturers is strengthened, the profit is expected to remain stable, and the cost of raw materials is expected to gradually fall, which is expected to continue to improve the fundamentals of the catalytic plate. In addition, the demand for power grid upgrading and construction and power base load maintenance under the “double carbon goal” is expanding. It is suggested to continue to pay attention to the growth opportunities of high-quality domestic leaders in the process of industry format upgrading and localization substitution.
From the perspective of industry style, Cinda Securities believes that the current pharmaceutical biology is turning from a good track to valuation repair. In 2021, there were frequent policies in the pharmaceutical industry, and the long-term investment value of innovative pharmaceutical machinery, pharmaceutical consumption, CXO and other racetracks still existed, but the short-term policies, performance and valuation needed to be digested. The investment style of the pharmaceutical industry turned to undervalued sectors. The valuation of traditional Chinese medicine, general medicine, low-value consumables, pharmacies and other sectors has fallen to the bottom, with the valuation of about 20 times, The valuation of some stocks has even fallen to about 10 times, which will usher in valuation repair in 2022.
(source: China Securities Journal)
